This inventor holds 2 USPTO granted patents. Top assignee: Aventis Pharma Limited. Active years: 2003-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Dagenham, GB (2003)
- Bernardsville, NJ (US) (2006)
Company Filing History:
Years Active: 2003-2006
Title: David J Lythgoe: Innovator in Pharmaceutical Chemistry
Introduction
David J Lythgoe is a notable inventor based in Bernardsville, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as inhibitors for various diseases.
Latest Patents
Lythgoe holds 2 patents, with his latest inventions focusing on imidazolyl-cyclic acetals. These compounds are designed to act as tumor necrosis factor (TNF) inhibitors, which are crucial in treating diseases associated with elevated TNF levels.
Career Highlights
Throughout his career, Lythgoe has worked with Aventis Pharma Limited, a leading company in the pharmaceutical industry. His work has been instrumental in advancing therapeutic options for patients suffering from TNF-related conditions.
Collaborations
Lythgoe has collaborated with esteemed colleagues such as Paul L Bamborough and Frank Halley, contributing to a dynamic research environment that fosters innovation.
Conclusion
David J Lythgoe's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a key figure in the development of new therapeutic agents. His work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile